Slavica Kvolik
Osijek, 31000, Croatia
NCT Number: NCT05798182
The aim of this study was to measure whether the flow rate through the brachial artery and inflammatory markers were associated with the development of tissue edema in the surgical intensive care unit patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Osijek, 31000, Croatia
The study was performed using a ultrasound machine with linear probe settings at 50 mm depth and 40 decibel [dB] gain that did not change during the study. The probe was placed on vascular ultrasound measurement. The diameter of the brachial artery in the middle of the upper arm and the flow rate through the artery was measured on postoperative days 1 and 2. The presence of the edema was measured above the 3rd metacarpal bone as the distance from the skin surface to the periosteum. An average of three assessments was shown. Patient's age, body mass index (BMI), type of admission, white blood cells (WBC), C-reactive protein (CRP), and procalcitonin (PCT) were also registered.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Study was conducted with Mindray T7 ultrasound machine using linear probe. Vascular ultrasound mode was used with settings depth of 50 mm and gain of 40 dB during the entire study period. The diameter and flow velocity of the brachial artery and wrist edema of the fist were measured within 24 hours of admission and the following day.
Other names: Mindray T7 ultrasound machine
Time frame: within 4 hours of admission.
Measurement of a brachial artery diameter [cm] at admission. Admission day is considered as day 1.
Time frame: day 2 after admission is between 24 and 48 hours after admission.
measurement of a brachial artery diameter [cm] on day 2 after admission.
Time frame: within 4 hours of admission to ICU.
measurement of a brachial artery flow velocity [cm/s] at admission.
Time frame: day 2 after admission is between 24 and 48 hours after admission.
measurement of a brachial artery flow velocity [cm/s] on day 2 after admission. Day 2 is Measurement of a brachial artery flow velocity [cm/s] between 24 and 48 h after ICU admission.
Time frame: within 4 hours of admission.
measurement of a distance from the skin to third metacarpal bone (cm) at admission.
Time frame: day 2 after admission is between 24 and 48 hours after admission.
measurement of a distance from the skin to third metacarpal bone (cm) on day 2 after admission.
Time frame: within 4 hours of admission.
blood sample analysis for white blood cell count (WBC [10^9/L]) at admission.
Time frame: day 2 after admission is between 24 and 48 hours after admission.
blood sample analysis for white blood cell count (WBC [10^9/L]) on day 2 after admission.
Time frame: within 4 hours of admission.
blood sample analysis for C-reactive protein (CRP [mg/L]) concentration at admission.
Time frame: day 2 after admission is between 24 and 48 hours after admission.
Blood sample analysis for C-reactive protein (CRP [mg/L]) concentration on day 2 after admission.
Time frame: within 4 hours of admission.
blood sample analysis for Procalcitonin concentration (PCT [ug/L]) at admission.
Time frame: Day 2 after admission is between 24 and 48 hours after admission.
Blood sample analysis for Procalcitonin concentration (PCT [ug/L]) on day 2 after admission.
Osijek University Hospital
Other
Ultrasound in the Intensive Care Unit and Measurable Indicators of Systemic Inflammation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07461012
CKD, Endothelial Dysfunction
Cairo, Egypt
View Trial DetailsNCT07274982
Endothelial Dysfunction, Erectile Dysfunction
Hatay, Defne, Turkey (Türkiye)
View Trial DetailsNCT05379608
Arrhythmia, Arrhythmias, Cardiac
Moscow, Russia
View Trial DetailsNCT04181398
Body Weight, Cardiovascular Risk Factor
Brussels, Belgium
View Trial Details